Evidence map›Paper›PMID 35619747›Full record

ArticleSAGE open medical case reports2022

Unique

Maurício Fernando Silva Almeida Ribeiro, Luiza Lara Gadotti, Karina Perez Sacardo, Carlos Diego Holanda Lopes, Rodrigo Saddi, João Victor Machado Alessi, Mariana Petaccia de Macedo, Ellen Caroline Toledo do Nascimento, Leonardo de Abreu Testagrossa, Artur Katz

Open access · goldAbstract readCase Reports
In one paragraph

Article in SAGE open medical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Maurício Fernando Silva Almeida RibeiroOncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-5602-164X
Luiza Lara GadottiOncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
Karina Perez SacardoOncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
Carlos Diego Holanda LopesOncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
Rodrigo SaddiOncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
João Victor Machado AlessiOncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.
Mariana Petaccia de MacedoDepartment of Pathology, Hospital Sírio-Libanês, São Paulo, Brazil.
Ellen Caroline Toledo do NascimentoDepartment of Pathology, Hospital Sírio-Libanês, São Paulo, Brazil.
Leonardo de Abreu TestagrossaDepartment of Pathology, Hospital Sírio-Libanês, São Paulo, Brazil.
Artur KatzOncology Center, Hospital Sírio-Libanês, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-1811-1169
Hospital Sírio-Libanês · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosomal rearrangements involving the c-ros oncogene 1 (

Indexed as

case reportcrizotinibmolecular targeted therapynon-small cell lung cancerROS1 proto-oncogene

Identifiers

PMID35619747
PMCPMC9127844
OpenAlexW4285216835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.